相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Horizon of Nanoparticle and Cluster Catalysis with Dendrimers
Kimihisa Yamamoto et al.
CHEMICAL REVIEWS (2020)
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
Mohamad Sabbah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Drug-Resistant Tuberculosis 2020: Where We Stand
Angelo Iacobino et al.
APPLIED SCIENCES-BASEL (2020)
The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives
Morgan Maiolini et al.
MOLECULES (2020)
Applications and Limitations of Dendrimers in Biomedicine
Adriana Aurelia Chis et al.
MOLECULES (2020)
Integrated POSS-dendrimer nanohybrid materials: current status and future perspective
Zhan Li et al.
NANOSCALE (2020)
Exploration of biomedical dendrimer space based on in-vivo physicochemical parameters: Key factor analysis (Part 2)
Serge Mignani et al.
DRUG DISCOVERY TODAY (2019)
Exploration of biomedical dendrimer space based on in-vitro physicochemical parameters: key factor analysis (Part 1)
Serge Mignani et al.
DRUG DISCOVERY TODAY (2019)
Poly(amidoamine) dendrimers: covalent and supramolecular synthesis
Z. Lyu et al.
MATERIALS TODAY CHEMISTRY (2019)
Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities
Kiran Patil et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
Serge Mignani et al.
PHARMACEUTICS (2018)
Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis
Serge Mignani et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Original Multivalent Gold(III) and Dual Gold(III)-Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents
Serge M. Mignani et al.
MOLECULAR PHARMACEUTICS (2017)
MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Emily A. Kendall et al.
PLOS ONE (2017)
Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance
Julie Laborde et al.
CHEMMEDCHEM (2017)
How can nanoparticles contribute to antituberculosis therapy?
Joana Costa-Gouveia et al.
DRUG DISCOVERY TODAY (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Identifying compound efficacy targets in phenotypic drug discovery
Markus Schirle et al.
DRUG DISCOVERY TODAY (2016)
Antimicrobial molecular nanocarrier-drug conjugates
Andrzej S. Skwarecki et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Riya Moodley et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer
Reinaldo G. Bellini et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
Cationic phosphorus dendrimers and therapy for Alzheimer's disease
Tomasz Wasiak et al.
NEW JOURNAL OF CHEMISTRY (2015)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Future target-based drug discovery for tuberculosis?
Bavesh Davandra Kana et al.
TUBERCULOSIS (2014)
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview
Serge Mignani et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences
Art D. Bochevarov et al.
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2013)
Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment
Emilyne Blattes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry
Serge Mignani et al.
PROGRESS IN POLYMER SCIENCE (2013)
Dendritic phosphoramidite ligands for Rh-catalyzed [2+2+2] cycloaddition reactions: unprecedented enhancement of enantiodiscrimination
Lidia Garcia et al.
CHEMICAL COMMUNICATIONS (2012)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Phase II failures: 2008-2010
John Arrowsmith
NATURE REVIEWS DRUG DISCOVERY (2011)
Design of Bisphosphonate-Terminated Dendrimers
Emma Cavero et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)
Dendrimers as therapeutic agents: a systematic review
Virendra Gajbhiye et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Polycationic phosphorus dendrimers: synthesis, characterization, study of cytotoxicity, complexation of DNA, and transfection experiments
Clement Padie et al.
NEW JOURNAL OF CHEMISTRY (2009)
Palladium(0) nanoparticles stabilized by phosphorus dendrimers containing coordinating 15-membered triolefinic macrocycles in periphery
Elena Badetti et al.
LANGMUIR (2008)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
Palanirajan Vijayaraj Kumar et al.
JOURNAL OF DRUG TARGETING (2006)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Cationic phosphorus-contain ing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie
J Solassol et al.
JOURNAL OF GENERAL VIROLOGY (2004)
分享论文
